Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Grey Defence: The #1 Grey Hair Reversing Pill With Enteric Coating Available For In-Licensing

Popular

Description

COORGA Nutraceuticals Corporation is pleased to announce In-licensing opportunities for Grey Defence. COORGA Nutraceuticals is looking for international partners in specific countries for out-license partnerships. This opportunity is for licensed distribution of finished product under exclusive long-term arrangements.

bottles_trans.pngCOORGA Nutraceuticals Corporation has identified 52 key countries in Europe, Asia and the Americas where it seeks in-license distribution partners.

 

Ideal in-license candidates will have strong, established distribution capabilities, including but not limited to warehousing and channel-direct sales force calling on pharmacies, supermarkets, mass merchandisers and health food stores. Potential partners must be experienced and sophisticated Nutraceuticals in-licensees able to independently conduct their own market analysis to determine the potential for Grey Defence® in their local markets and not be reliant on COORGA Nutraceuticals to conduct such analysis on their behalf. In addition, in-licensing candidates must possess the financial capacity to purchase inventory to satisfy out-license contract terms.

 

http://www.greydefence.com/what-is-grey-defence/outlicensing/

 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 784

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
783 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
645 Views
Profitable and Modern Russian CMO with long...
610 Views
Adalimumab API available: - from EU cGMP...
10357 Views
Infliximab API available: - from EU cGMP...
626 Views
Normal 0 false false false EN-US X-NONE HE /*...
603 Views
Start-up pharmaceutical company from South...
2054 Views